Institution profile

医療法人社団恵仁会なぎ辻病院

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02E2601015 +5

Location

Prefecture
Kyoto
Address
京都市山科区椥辻東潰5番1

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIINot registered

Certified committee for regenerative medicine

  • 医療法人財団康生会武田病院特定認定再生医療等委員会

Public score

59.1/ 100

A · Review level
25.0 / 30
B · Technologies
22.4 / 35
C · Coverage
3.6 / 25
D · Class I / II technologies
8.1 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 211of 1736

Registered technologies
6
Areas covered
1

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 59.1
Public score →100

Registered technologies (6)

Stem cells (all sources) 6
Registered technologies · Japanese originalTechnology areasPlan classification
アルツハイマー型認知症に対するヒト脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II
パーキンソン病に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II
難治性神経変性疾患(筋萎縮性側索硬化症〈ALS〉、脊髄小脳変性症〈SCD〉、レビー小体病〈DLB〉、進行性核上性麻痺〈PSP〉)に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II
難治性呼吸器間質性疾患(肺気腫<COPDを含む>、特発性肺線維症<IPF>、間質性肺炎)に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II
動脈硬化症に対するヒト脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己免疫疾患に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 6
Registered technologies · Japanese originalTechnology areasPlan classification
アルツハイマー型認知症に対するヒト脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II
パーキンソン病に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II
難治性神経変性疾患(筋萎縮性側索硬化症〈ALS〉、脊髄小脳変性症〈SCD〉、レビー小体病〈DLB〉、進行性核上性麻痺〈PSP〉)に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II
難治性呼吸器間質性疾患(肺気腫<COPDを含む>、特発性肺線維症<IPF>、間質性肺炎)に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II
動脈硬化症に対するヒト脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己免疫疾患に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Stem cells (all sources)Adipose-derived stem cellsClass II

Certified committee for regenerative medicine

  • 医療法人財団康生会武田病院特定認定再生医療等委員会

Public document number

  • 02E2601015
  • 02E2601016
  • 02E2601020
  • 02E2601017
  • 02E2601018
  • 02E2601019
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
アルツハイマー型認知症に対するヒト脂肪組織由来間葉系幹細胞を用いた治療Class II医療法人財団康生会武田病院特定認定再生医療等委員会02E2601015
パーキンソン病に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Class II医療法人財団康生会武田病院特定認定再生医療等委員会02E2601016
自己免疫疾患に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Class II医療法人財団康生会武田病院特定認定再生医療等委員会02E2601020
難治性神経変性疾患(筋萎縮性側索硬化症〈ALS〉、脊髄小脳変性症〈SCD〉、レビー小体病〈DLB〉、進行性核上性麻痺〈PSP〉)に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Class II医療法人財団康生会武田病院特定認定再生医療等委員会02E2601017
難治性呼吸器間質性疾患(肺気腫<COPDを含む>、特発性肺線維症<IPF>、間質性肺炎)に対するヒト自己脂肪組織由来間葉系幹細胞を用いた治療Class II医療法人財団康生会武田病院特定認定再生医療等委員会02E2601018
動脈硬化症に対するヒト脂肪組織由来間葉系幹細胞を用いた治療Class II医療法人財団康生会武田病院特定認定再生医療等委員会02E2601019

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor